Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population
NCT01755637
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Helminthiasis
Interventions
DRUG:
Albendazole
Sponsor
GlaxoSmithKline